KAPA Projected Dividend Yield
Kairos Pharma Ltd ( AMEX : KAPA )Kairos Pharma is a clinical-stage biopharmaceutical company that engaged in the development of a diversified pipeline of cutting-edge oncology therapeutics born from structural biology to reverse cancer drug resistance and the inhibitory effects of cancer on the immune system. Co. is advancing its portfolio of innovative drug candidates designed to reverse resistance and immune suppression from cancer. 21 YEAR PERFORMANCE RESULTS |
KAPA Dividend History Detail KAPA Dividend News KAPA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |